Your session is about to expire
← Back to Search
Behavioral Intervention
Motivational Interviewing for Hearing Loss (MI-HAT Trial)
N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years and older
Be older than 18 years old
Must not have
Unable to complete the online questionnaires in English language
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study assessments will be performed during the initial visit, and at 1, 3, 6 and 12-month time points.
Awards & highlights
No Placebo-Only Group
Summary
This trial will test the feasibility and effectiveness of an 8-week group MI intervention for people with hearing loss.
Who is the study for?
This trial is for adults over 18 who are new to using hearing aids and have a certain level of hearing loss in one or both ears. They must understand English as the motivational interviewing and questionnaires will be in this language. People with previous hearing aid experience, inconsistent hearing tests, or medical issues preventing hearing aid use cannot join.
What is being tested?
The study is testing whether motivational interviewing (MI), a type of counseling that encourages behavior change, can increase the use of hearing aids among new users. It aims to address fears and shame associated with wearing aids by fostering motivation.
What are the potential side effects?
Since MI involves counseling without medications or invasive procedures, there aren't typical side effects like those seen with drugs or surgery. However, participants may experience emotional discomfort discussing personal challenges related to their hearing loss.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot complete questionnaires in English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ study assessments will be performed during the initial visit, and at 1, 3, 6 and 12-month time points.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study assessments will be performed during the initial visit, and at 1, 3, 6 and 12-month time points.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hearing aid use hours
Patient reported outcomes
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
Treatment groups that undergo motivational interviewing with audiological care
Group II: ControlActive Control1 Intervention
Control groups that undergo standard audiological care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational interviewing
2011
Completed Phase 3
~7250
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,481 Previous Clinical Trials
2,494,736 Total Patients Enrolled
2 Trials studying Hearing Loss
199 Patients Enrolled for Hearing Loss
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot complete questionnaires in English.Your hearing in the worse ear is not very good, with a hearing threshold above 25 decibels at certain frequencies.You have used a hearing aid in the past.Your hearing test results are not consistent.I am 18 years old or older.You recently started using a hearing aid.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.